Pharmascience
Philip Bertin possesses extensive experience in finance, currently serving as Finance Business Partner for Pharmascience Canada and Pendopharm since June 2016, alongside roles as Finance Business Partner for R&D and Finance Manager for both Corporate Accounting and Global Operations. Prior to joining Pharmascience, Philip worked at L'Oréal from May 2012 to June 2016, advancing from Financial Analyst to Senior Financial Analyst. Philip holds a CPA, CMA designation from Chartered Professional Accountants of Canada (2012-2014) and a Bachelor of Business Administration (BBA) in Accounting from HEC Montréal (2009-2012).
This person is not in any teams
Pharmascience
2 followers
R&D and manufacturing of varied ethical, generic pharmaceutical, dental and dermatological products. Export of finished generic products around the world. Joint venture possibilities with exhange of technology and co-development of products.